Alexandria Real Estate Equities NYSE: ARE
Alexandria Real Estate Equities, Inc. is a real estate investment (REIT). The Company is engaged in the business of providing space for lease to the life science and technology industries
Name | Alexandria Real Estate Equities |
Ticker | ARE |
Exchange | NYSE |
Sector | Real Estate |
Industry | REITs Health Care & Senior Housing |
Price | 168.37 |
52W Low/High | 114.92 / 178.22 |
Market cap | 21 B |
1Y Total Return |
5.37%
Average |
1Y Volatility |
42.67%
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Alexandria Real Estate Equities, Inc. is a real estate investment (REIT). The Company is engaged in the business of providing space for lease to the life science and technology industries
Details
Ticker | ARE |
Name | Alexandria Real Estate Equities |
ISIN | US0152711091 |
CUSIP | 015271109 |
Exchange | NYSE |
Sector | Real Estate |
Industry | REITs Health Care & Senior Housing |
Country | USA |
Currency | U.S. Dollar |
In Index(ices) | US S&P 500 Index |
Share as of 1/15/21
Close Price | 168.37 |
52W Low/High | 114.92 / 178.22 |
Market cap | 21 B |
1Y Total Return |
5.37%
Average |
1Y Volatility |
42.67%
Low Risk |
Beta | 0.83 |
PE (trailing) |
38.62
Above Average |
12M Dividends | 4.18 |
Last Dividend Date | 12/30/20 |
Dividend Yield | 2.48% |
Fin. Strength
Net Profit Margin | 28.6% |
Cash from Op. / Cur. Liabilities | - |
Diluted Earnings / Share | 4.36 |
ROE | 5.7% |
ROIC | 7.0% |
Price / Revenue | - |
Price / Book | - |
Price / CF | - |
Current Ratio | - |
Cur.Liabilities / Tot.Liabilities | - |
Financial Leverage | 0.73 |
in Mils USD |
rolling-year up to September
|
||||||
---|---|---|---|---|---|---|---|
Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
Revenue |
1,830
|
1,464
|
1,286
|
1,078
|
896
|
808
|
|
Gross Profit |
1,315
|
1,042
|
914
|
768
|
622
|
559
|
|
R&D |
0
|
0
|
0
|
0
|
0
|
0
|
|
EBITDA |
1,372
|
834
|
1,057
|
673
|
355
|
442
|
|
Operating Income |
490
|
412
|
361
|
274
|
69
|
187
|
|
Net Income exc. Extra |
532
|
136
|
443
|
145
|
-
|
95
|
|
per Share | |||||||
Diluted avg Shares |
-
|
-
|
-
|
-
|
-
|
-
|
|
EPS exc. Extra |
4.36
|
1.02
|
4.20
|
0.89
|
-1.21
|
0.92
|
|
Dividend |
4.18
|
3.94
|
3.66
|
3.38
|
3.17
|
3.02
|
|
Div. Yield (an.) |
2.61%
|
2.56%
|
2.91%
|
2.84%
|
2.91%
|
3.57%
|
|
Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
Total Assets |
21,911
|
17,058
|
14,106
|
11,545
|
9,294
|
8,737
|
|
Cash, Eq & Invt ShortTerm |
-
|
-
|
-
|
-
|
-
|
-
|
|
Total Current Assets |
-
|
-
|
-
|
-
|
-
|
-
|
|
Total Non-Current Assets |
-
|
-
|
-
|
-
|
-
|
-
|
|
Intangibles |
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
9,576
|
8,095
|
6,692
|
5,641
|
5,001
|
4,962
|
|
Total Current Liabilities |
-
|
-
|
-
|
-
|
-
|
-
|
|
Long Term Debt |
-
|
-
|
-
|
-
|
-
|
-
|
|
Shareholder equity |
10,702
|
7,790
|
6,873
|
5,407
|
3,910
|
3,759
|
|
Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
Cash from Operations |
887
|
662
|
508
|
459
|
388
|
326
|
|
Depreciation |
661
|
529
|
460
|
404
|
290
|
247
|
|
Cash from Investing |
-4,155
|
-2,748
|
-2,188
|
-2,097
|
-880
|
-718
|
|
Capex |
4,335
|
2,543
|
1,911
|
2,056
|
702
|
741
|
|
Cash from Financing |
3,301
|
2,306
|
1,768
|
1,596
|
575
|
403
|
|
Stock Issued |
2,795
|
832
|
1,267
|
1,770
|
441
|
5
|
|
Debt (LT) Issued |
1,043
|
1,010
|
875
|
264
|
46
|
727
|
|
Free Cash Flow |
-
|
-
|
-
|
-
|
-
|
-
|
|
Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
Net Profit Margin |
28.6%
|
8.2%
|
33.5%
|
7.7%
|
-
|
8.1%
|
|
NCFO / Op.Income |
181.2%
|
160.7%
|
140.8%
|
167.7%
|
566.5%
|
173.7%
|
|
Current Ratio |
-
|
-
|
-
|
-
|
-
|
-
|
|
Financial Leverage D/E |
0.73
|
0.86
|
0.83
|
0.89
|
1.11
|
1.15
|
|
Return on Capital Avg |
7.0%
|
3.9%
|
9.2%
|
5.4%
|
1.7%
|
5.2%
|
|
Return on Shareholder Equity |
5.7%
|
1.6%
|
7.0%
|
1.8%
|
-
|
1.7%
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available